Community Fitness Program Tackles Obesity and Pain in High-Risk Urban Adults
A completed trial tests whether a person-centered exercise and weight-management program can reduce obesity and pain in Camden, NJ adults.
Summary
The HealthyWE trial enrolled 89 adults aged 19 and older in Camden City, New Jersey — a community with an adult obesity rate of 44.1% — to test a person-centered integrative intervention aimed at weight reduction, pain relief, improved quality of life, and better mental health. Obesity accelerates many hallmarks of aging, including cardiovascular disease, type 2 diabetes, hypertension, and chronic pain, making it a direct threat to healthspan. The program addressed not just individual barriers like limited time and physical capability, but also environmental obstacles such as unsafe neighborhoods and extreme weather. By building local community capacity, HealthyWE aimed to create sustainable obesity-prevention infrastructure in an underserved urban setting. The trial completed in August 2025, sponsored by Rutgers University.
Detailed Summary
Obesity is one of the most powerful accelerants of biological aging. It amplifies risk for cardiovascular disease, type 2 diabetes, hypertension, dyslipidemia, chronic pain, and depression — all conditions that erode healthspan and compress the years of functional independence. In communities like Camden, New Jersey, where 44.1% of adults live with obesity, these risks are compounded by systemic and environmental barriers to physical activity.
The HealthyWE trial enrolled 89 adults aged 19 and older and delivered an adapted, person-centered integrative intervention called the HealthyWE: Keeping a Healthy Weight program. The primary aims were to reduce and manage obesity, increase self-efficacy around weight maintenance, alleviate pain, improve quality of life, and reduce mental health symptoms. The program was specifically designed to address multilevel barriers — personal (time constraints, physical capability, competing demands), environmental (lack of safe outdoor spaces), climatic (heat waves limiting outdoor activity), and systemic (limited program availability).
By targeting self-efficacy alongside physical activity, the intervention acknowledged that sustainable weight management requires psychological empowerment, not just exercise prescription. This is especially relevant for older adults, whose motivation and confidence to remain active often diminish as physical capacity declines.
The trial was completed in August 2025, with Rutgers University as the sponsoring institution. By building community capacity and infrastructure in Camden, the project aimed to leave lasting systems for obesity prevention that extend beyond the trial itself.
Several caveats apply. The abstract does not report outcome data, so efficacy conclusions cannot yet be drawn. The single-city community setting and the non-randomized, Phase N/A design limit generalizability. Additionally, this summary is based on the abstract only, as the full study record was not available.
Key Findings
- The program targeted both individual and environmental barriers to physical activity in a high-obesity urban community.
- 89 adults aged 19 and older were enrolled, exceeding the original goal of 60 participants.
- Outcomes tracked included weight, pain, quality of life, mental health, and self-efficacy.
- A community-capacity-building model was used to sustain obesity prevention beyond the trial period.
- Camden's 44.1% adult obesity rate underscores the urgent need for scalable community-based interventions.
Methodology
This is a completed community-based intervention trial (Phase N/A) enrolling 89 adults aged 19 and older in Camden City, NJ, running from June 2023 to August 2025. The HealthyWE program was a person-centered integrative intervention adapted for an urban, underserved population. No control arm or randomization details are described in the available abstract.
Study Limitations
This summary is based on the abstract only; full methodology, outcome data, and statistical results are not available. The trial lacks a described control arm, limiting causal inference about the intervention's effectiveness. The single-city urban setting and community-specific adaptations may restrict generalizability to other populations.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: